Page 25 - Biocon Biologics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biocon biologics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biocon Biologics Today - Breaking & Trending Today

Biocon: Biocon weighs sale of $1.5 billion generic API business

The Kiran Mazumdar-Shaw helmed company made a huge bet on biosimilars by acquiring a portfolio of drugs from global drug major Viatris for $3.34 billion in November last year. That deal was funded by debt taken both by Biocon Ltd and its biosimilars arm Biocon Biologics. Biocon Biologics took loans of $1.2 billion to fund the acquisition. ....

Kiran Mazumdar Shaw , Biocon Biologics , Biocon Ltd , Generic Api Business ,

Biocon denies plans to sell $1.5 billion generic API business

Biocon API business: Biocon has refuted claims of considering the sale of its generic active pharmaceutical ingredient (API) business, valued at $1.5 billion, to alleviate its debt burden. A company spokesperson clarified they were not assessing divestment options or seeking advice from bankers, countering an ET report based on insights from familiar sources. ....

Kiran Mazumdar Shaw , Biocon Biologics , Biocon Ltd , Biocon Limited , Generic Formulations , Biocon Api Business , Biocon Api Business Sale , Biocon Api Business Valuation , Api Business , Stake Sale , Mergers And Acquisitions , Biocon Stake Sale , Biocon Business Divestment ,

Biocon Considers $1.5 Billion Sale Of Generic API Business To Cut Debt

Biocon Considers $1.5 Billion Sale Of Generic API Business To Cut Debt
outlookindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outlookindia.com Daily Mail and Mail on Sunday newspapers.

Kiran Mazumdar Shaw , Biocon Biologics , Biocon Ltd ,